Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

Clinical trial NCT07282054 · COMPLETED

Trial details

NCT number: NCT07282054
Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-04-13
Primary completion: 2025-01-23
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.